Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.

The Journal of molecular diagnostics : JMD·2026
Same author

<sup>68</sup>Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of <sup>68</sup>Ga-FAPI-46 with <sup>18</sup>F-FDG in 13 patients.

European journal of nuclear medicine and molecular imaging·2026
Same author

Uterine mesenchymal neoplasm harbouring an AKAP9::BRAF fusion: identification of a novel kinase-driven molecular subset.

Virchows Archiv : an international journal of pathology·2026
Same author

An agentic framework for autonomous scientific discovery in cancer pathology.

Nature medicine·2026
Same author

Schlafen 11 as a prognostic and potentially predictive biomarker in soft tissue sarcoma: evidence from a real-world cohort.

Frontiers in oncology·2026
Same author

Immune cell clustering identifies a CD163⁺/CSF1R⁺ macrophage and neutrophil-enriched phenotype with distinct biological signatures and poor prognosis in angiosarcoma.

Oncoimmunology·2026

Related Experiment Video

Updated: Apr 28, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K

Changing histopathological diagnostics by genome-based tumor classification.

Michael Kloth1, Reinhard Buettner2

  • 1Institute of Pathology, University Hospital Cologne, Kerpener Str. 62, Cologne D-50937, Germany. michael.kloth@uk-koeln.de.

Genes
|June 1, 2014
PubMed
Summary
This summary is machine-generated.

Genomic data is revolutionizing cancer classification, moving beyond traditional histology to molecular drivers. This enables personalized therapies and improved diagnostic information for better patient outcomes.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Related Experiment Videos

Last Updated: Apr 28, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Traditional tumor classification relies on histopathology, influencing current cancer treatment decisions.
  • Advances in genomics and molecular biology necessitate integrating genomic information into disease classification.
  • Existing classifications sometimes require revision based on molecular pathogenesis insights.

Purpose of the Study:

  • To summarize genome-based cancer classification approaches.
  • To review associated targeted therapeutic concepts.
  • To highlight the role of molecular diagnostics in disease monitoring.

Main Methods:

  • Review of scientific literature on genome-based cancer classification.
  • Analysis of molecular and genomic data integration in oncology.
  • Examination of therapeutic and predictive markers.

Main Results:

  • Genomic classification enhances diagnostic information content.
  • Molecular drivers identified enable targeted and effective therapies.
  • Reclassification based on molecular pathogenesis optimizes treatment decisions.

Conclusions:

  • Genome-based classification refines cancer diagnoses by reflecting molecular pathogenesis.
  • Integration of genomic data leads to optimized, individualized therapeutic strategies.
  • Molecular diagnostics are crucial for disease monitoring and treatment selection.